Do statins work similarly for patients with severe mental illness?
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
Statin prescribing to patients with severe mental illness (SMI) was associated with similar level of benefit to the general population with observed reductions for total cholesterol of 1.2 mmol/L up to 2 y.
This suggests that medication adherence is sufficient for effective lipid modifications.
Why this matters
Compared with patients without SMI, those with SMI including schizophrenia and bipolar disorder are at a higher risk for cardiovascular disease.
Study included patients diagnosed with SMI (age, 40-84 y) who were exposed to 1 or more statin prescription during a 24-mo ‘baseline’ period.
Primary outcome was combined first myocardial infarction (MI) and stroke; secondary outcome included all-cause mortality and total cholesterol concentration.